Blueprint Medicines (BPMC) Stock Jumps 18.2%: Will It Continue to Soar?

Blueprint Medicines (BPMC) shares ended the last trading session 18.2% higher at $103.36. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 6.2% loss over the past four weeks.The sudden soaring of the stock price was observed after Blueprint announced its 2025 corporate outlook and growth strategy, highlighting plans to build on its established R&D and commercial expertise. Growth in 2025 is expected to be fuelled by ...